Brown Advisory Sustainable Small-Cap Core Strategy Q1 2026 Portfolio Activity

First Financial Bancorp maintains a return on tangible common equity in the high teens, and we were able to buy the stock at an attractive valuation. We purchased shares of Guardant Health, as recent due diligence highlighted a stable competitive environment and underscored a number of positive catalysts for the company over the next several years. We exited our position in Dynatrace, Inc. to redeploy capital to other higher conviction names following the broad software de-rating.

Seeking Alpha • May 1, 2026

LifeStance to Present at Upcoming Investor Conferences

SCOTTSDALE, Ariz., April 29, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced that management will present at the following upcoming investor conferences.

GlobeNewsWire • Apr 29, 2026

New Strong Buy Stocks for April 28th

APA, MPC, PSX, LFST and GLPEY have been added to the Zacks Rank #1 (Strong Buy) List on April 28th, 2026.

Zacks Investment Research • Apr 28, 2026

LifeStance Publishes Outcomes Data Validating the Benefit of Mental Health Treatment at Scale

Analysis of 180,000 Patients Validates Measurement-Informed Care for Anxiety and Depression SCOTTSDALE, Ariz., April 9, 2026 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of outpatient mental health care, published new clinical outcomes data demonstrating that LifeStance patients treated for anxiety and depression broadly experienced clinically significant improvements in their symptoms.

PRNewsWire • Apr 9, 2026

LifeStance Health Group, Inc. (LFST) Q4 2025 Earnings Call Transcript

LifeStance Health Group, Inc. (LFST) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 26, 2026

LifeStance Reports Fourth Quarter and Full Year 2025 Results

SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2025.

GlobeNewsWire • Feb 25, 2026

LifeStance Health Group (LFST) Q4 Earnings and Revenues Top Estimates

LifeStance Health Group (LFST) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of breakeven. This compares to a loss of $0.02 per share a year ago.

Zacks Investment Research • Feb 25, 2026

LifeStance Health Group Announces Launch of Secondary Public Offering

SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”), certain stockholders of the Company (the “Selling Stockholders”) intend to offer 25,000,000 shares of LifeStance's common stock, par value $0.01 per share (the “Common Stock”). The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive any proceeds from the offering.

GlobeNewsWire • Feb 25, 2026

LifeStance to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on February 25, 2026

SCOTTSDALE, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2025 earnings release before the market opens on Wednesday, February 25, 2026.

GlobeNewsWire • Feb 9, 2026

Wall Street Analysts Think LifeStance Health (LFST) Could Surge 30.49%: Read This Before Placing a Bet

The mean of analysts' price targets for LifeStance Health (LFST) points to a 30.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Investment Research • Nov 28, 2025